Amgen Balance Sheet Health
Financial Health criteria checks 1/6
Amgen has a total shareholder equity of $10.0B and total debt of $128.0B, which brings its debt-to-equity ratio to 1274.8%. Its total assets and total liabilities are $186.0B and $175.9B respectively. Amgen's EBIT is $6.3B making its interest coverage ratio 1.8. It has cash and short-term investments of $19.4B.
Key information
1,274.8%
Debt to equity ratio
US$128.04b
Debt
Interest coverage ratio | 1.8x |
Cash | US$19.42b |
Equity | US$10.04b |
Total liabilities | US$175.92b |
Total assets | US$185.96b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: AMGN *'s short term assets ($56.1B) exceed its short term liabilities ($39.4B).
Long Term Liabilities: AMGN *'s short term assets ($56.1B) do not cover its long term liabilities ($136.5B).
Debt to Equity History and Analysis
Debt Level: AMGN *'s net debt to equity ratio (1081.5%) is considered high.
Reducing Debt: AMGN *'s debt to equity ratio has increased from 304.9% to 1274.8% over the past 5 years.
Debt Coverage: AMGN *'s debt is not well covered by operating cash flow (10.1%).
Interest Coverage: AMGN *'s interest payments on its debt are not well covered by EBIT (1.8x coverage).